Holen Sie sich die Stockscreener-App
272.89
1.09%
2.94
Handel nachbörslich:
272.89
Natera Inc Aktie (NTRA) Neueste Nachrichten
Enterprise value to EBITDA forward of Natera, Inc. – BX:NTRA - TradingView
[144] Natera, Inc. SEC Filing - Stock Titan
Enterprise value to EBITDA forward of Natera, Inc. – XETR:45E - TradingView
Did EU Class C Status for Signatera Reshape Natera’s (NTRA) Long-Term Diagnostics Strategy? - Yahoo Finance
What's Driving Natera's Recent Stock Action and Insider Selling - Kavout | AI
Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification? - simplywall.st
Natera (NTRA) Secures EU Certification, Is The Upside Already Priced In? - Yahoo Finance
Why Natera (NTRA) Stock Is Down Today - Quiver Quantitative
Natera (NTRA) Signatera Data Shows Who Benefits From Chemotherapy After CRC Surgery - Yahoo Finance
NTRA's Signatera Gains EU IVDR Certification for Multiple Cancers - Yahoo Finance
Natera (NTRA) Stock Still Looks Expensive After A Very Large Run - Yahoo Finance
NTRA Maintained by Morgan Stanley -- Price Target Raised to $310 - GuruFocus
Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $310 - Moomoo
Natera, Inc. Stock 12‑Month Price Target Raised to $272.19, Implies 1% Downside - TradingView
Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers - 01net
How New Signatera Colorectal Data and Trial Deals Could Shape Natera’s (NTRA) Long-Term Narrative - simplywall.st
Natera’s Signatera receives EU IVDR certification for MRD testing By Investing.com - Investing.com South Africa
Natera’s Signatera receives EU IVDR certification for MRD testing - Investing.com
Natera Receives EU IVDR Certification for Signatera - Moomoo
Natera (NTRA) Achieves Significant Milestone with Signatera IVDR Certification - GuruFocus
Natera's Insider Selling Spree: A Red Flag Amidst Robust Growth - Kavout | AI
Natera executive chairman Matthew Rabinowitz sells $280,000 in shares By Investing.com - Investing.com Nigeria
Natera executive chairman Matthew Rabinowitz sells $280,000 in shares - Investing.com
(NTRA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Form 4 Natera Inc For: 8 July By Investing.com - Investing.com Nigeria
Natera (NTRA) executive chair’s spouse sells 1,000 shares in pre‑planned trade - Stock Titan
Form 4 Natera Inc For: 6 July By Investing.com - Investing.com India
Natera president Solomon Moshkevich sells $818,710 in stock - Investing.com UK
Natera chief legal officer Daniel Rabinowitz sells $4.57m stock - Investing.com
Natera chief legal officer Daniel Rabinowitz sells $4.57m stock By Investing.com - Investing.com Australia
Natera | 4: Statement of changes in beneficial ownership of securities-Director Rubin Eric H - Moomoo
Natera president Solomon Moshkevich sells $818,710 in stock By Investing.com - Investing.com Australia
Natera (NTRA) president sells 3,000 shares under Rule 10b5-1 trading plan - Stock Titan
Natera (NTRA) legal chief sells 16,800 shares under Rule 10b5-1 plan - Stock Titan
Form 144 NATERA For: 6 July By Investing.com - Investing.com South Africa
Natera study shows MRD test predicts chemo benefit in liver cancer - Investing.com UK
Matthew Rabinowitz sells 50,000 shares — (NASDAQ: NTRA) - Stock Titan
Board member Monica Bertagnolli exits Natera (NASDAQ: NTRA) - Stock Titan
Natera study shows MRD test predicts chemo benefit in liver cancer By Investing.com - Investing.com South Africa
Natera demonstrates MRD test benefit in colorectal cancer patients - Medical Device Network
Natera publishes Signatera survival data in JAMA Oncology - grafa.com
Evercore Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $300 - Moomoo
Natera (NTRA) Gains Insight into Colorectal Cancer Treatment Out - GuruFocus
Signatera™ MRD Test Predicted Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer - Yahoo Finance
Natera, Inc. (NTRA) Stock Analysis: Navigating Growth Amidst Challenging Valuations - DirectorsTalk Interviews
Natera Q1 2026 slides: revenue jumps 39%, guidance raised - Investing.com
3 Healthcare Stocks Built For Higher Rates And Steady Demand - Sahm
Natera Inc focuses on genetic testing growth as investors watch Nasdaq trading - AD HOC NEWS
Natera (NTRA) Lands New Trial Partnerships, Is The Upside Already Priced In? - simplywall.st
NTRANatera Inc Options - Finviz
Natera stock hits all-time high at $279.63 By Investing.com - Investing.com South Africa
0.19%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):